Tulsi Mahadevia – Northstar Diagnostics & Pathology Lab

• Tulsi Mahadevia founded Northstar Diagnostics & Pathology Lab on February 1, 2020, establishing a significant presence in the diagnostics and pathology sector.
• As the Director, Tulsi Mahadevia has spearheaded initiatives to enhance diagnostic accuracy and efficiency in pathology services.
• Northstar Diagnostics & Pathology Lab has become known for its commitment to leveraging advanced technologies to improve patient outcomes.
• Under Tulsi Mahadevia's leadership, the lab has focused on building a comprehensive range of diagnostic tests, catering to diverse medical needs.
• Despite the challenges presented by the COVID-19 pandemic, Tulsi Mahadevia effectively guided the lab through the crisis, ensuring continued service delivery and adaptation to new health protocols.
• The organization has achieved notable milestones, including the successful implementation of streamlined processes for quicker result turnaround times.
• Collaboration with healthcare providers has been a cornerstone of operations, enhancing the lab’s reputation and fostering trust within the medical community.
• Tulsi Mahadevia has been proactive in pursuing industry certifications and accreditations, further establishing the credibility and reliability of Northstar Diagnostics & Pathology Lab.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Northstar Diagnostics & Pathology Lab corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Tulsi Mahadevia's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Northstar Diagnostics & Pathology Lab's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)